Literature DB >> 26251218

Correlation between the Stereochemistry and Bioactivity in Octahedral Rhodium Prolinato Complexes.

Rajathees Rajaratnam1, Elisabeth K Martin1, Markus Dörr1, Klaus Harms1, Angela Casini2,3, Eric Meggers1,4.   

Abstract

Controlling the relative and absolute configuration of octahedral metal complexes constitutes a key challenge that needs to be overcome in order to fully exploit the structural properties of octahedral metal complexes for applications in the fields of catalysis, materials sciences, and life sciences. Herein, we describe the application of a proline-based chiral tridentate ligand to decisively control the coordination mode of an octahedral rhodium(III) complex. We demonstrate the mirror-like relationship of synthesized enantiomers and differences between diastereomers. Further, we demonstrate, using the established pyridocarbazole pharmacophore ligand as part of the organometallic complexes, the importance of the relative and absolute stereochemistry at the metal toward chiral environments like protein kinases. Protein kinase profiling and inhibition data confirm that the proline-based enantiopure rhodium(III) complexes, despite having all of the same constitution, differ strongly in their selectivity properties despite their unmistakably mutual origin. Moreover, two exemplary compounds have been shown to induce different toxic effects in an ex vivo rat liver model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26251218     DOI: 10.1021/acs.inorgchem.5b01349

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

2.  Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound.

Authors:  Li-Juan Liu; Wanhe Wang; Shi-Ying Huang; Yanjun Hong; Guodong Li; Sheng Lin; Jinglin Tian; Zongwei Cai; Hui-Min David Wang; Dik-Lung Ma; Chung-Hang Leung
Journal:  Chem Sci       Date:  2017-05-16       Impact factor: 9.825

3.  Synthesis, Characterization, and Antiproliferative Activity of Novel Chiral [QuinoxP*AuCl2]+ Complexes.

Authors:  Adedamola S Arojojoye; R Tyler Mertens; Samuel Ofori; Sean R Parkin; Samuel G Awuah
Journal:  Molecules       Date:  2020-12-04       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.